Chuck Triano
Senior Vice President and Head of Investor Relations
Replay available
Bristol-Myers Squibb Company (BMY) Q3 2025 Earnings Call
Bristol-Myers Squibb Company (NYSE: BMY) Q3 2025 earnings conference call, held 2025-10-30. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Chris Berner
Board Chair and Chief Executive Officer
David Elkins
Chief Financial Officer
Chris Schott
Analyst, J.P. Morgan
Christian Massachesi
Chief Medical Officer and Head of Global Drug Development
Adam Lankowski
Chief Commercialization Officer
Jeff Meechan
Analyst, Citi
Evan Siegerman
Analyst, BMO Capital Markets
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Bristol-myers Squibb Company.
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:06.219 Welcome to the Bristol-Myers Squibb Third Quarter 2025 Earnings Conference Call. 00:00:06.219 -- 00:00:09.603 All participants will be in a listen-only mode. 00:00:09.603 -- 00:00:13.468 Should you need assistance, please signal a conference specialist by pressing the star 00:00:13.468 -- 00:00:16.071 key followed by zero. 00:00:16.071 -- 00:00:21.217 After today's presentation, there will be an opportunity to ask questions. 00:00:21.217 -- 00:00:26.043 To ask a question, you may press star, then one on your telephone keypad. 00:00:26.043 -- 00:00:30.119 To withdraw your question, please press star, then two. 00:00:30.119 -- 00:00:33.127 Please note this event is being recorded. 00:00:33.127 -- 00:00:38.021 I would now like to turn the conference over to Chuck Triano, Senior Vice President and 00:00:38.021 -- 00:00:42.327 Head of Investor Relations. Please go ahead. 00:00:42.775 -- 00:00:46.499 Thank you and good morning, everyone. We appreciate you joining our third quarter 2025 00:00:46.499 -- 00:00:51.445 earnings call. With me this morning with prepared remarks are Chris Berner, our board 00:00:51.445 -- 00:00:56.270 chair and chief executive officer, and David Elkins, our chief financial officer. 00:00:56.270 -- 00:01:01.316 Also participating in today's call is Adam Lankowski, our chief commercialization officer, 00:01:01.316 -- 00:01:06.121 and we welcome Christian Massachesi, our recently appointed chief medical officer and 00:01:06.121 -- 00:01:10.616 head of global drug development. Earlier this morning, we posted our quarterly slide 00:01:10.616 -- 00:01:15.904 presentation to BMS.com that you can use to follow along with Chris and David's remarks. 00:01:15.904 -- 00:01:19.870 Before we get started, I'll remind everybody...